Traditionally Conservative, Pharma's Debt Load is Rising
This article was originally published in The Pink Sheet Daily
Executive Summary
A Moody's report tracks trends in the financially risk-averse pharma industry, noting that M&A activity and share buyback programs are pushing leverage up and debt ratings down.